-
Something wrong with this record ?
A Comparative Analysis of Multipotent Mesenchymal Stromal Cells derived from Different Sources, with a Focus on Neuroregenerative Potential
Y. Petrenko, I. Vackova, K. Kekulova, M. Chudickova, Z. Koci, K. Turnovcova, H. Kupcova Skalnikova, P. Vodicka, S. Kubinova,
Language English Country Great Britain
Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
Nature Open Access
from 2011-12-01
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
Springer Nature OA/Free Journals
from 2011-12-01
- MeSH
- Cell Differentiation * MeSH
- Bone Marrow Cells cytology metabolism MeSH
- Cells, Cultured MeSH
- Humans MeSH
- Mesenchymal Stem Cells cytology metabolism MeSH
- Neural Stem Cells cytology metabolism MeSH
- Cell Proliferation MeSH
- Nerve Regeneration * MeSH
- Adipose Tissue cytology metabolism MeSH
- Wharton Jelly cytology metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
Multipotent mesenchymal stromal cells (MSCs) can be considered an accessible therapeutic tool for regenerative medicine. Here, we compared the growth kinetics, immunophenotypic and immunomodulatory properties, gene expression and secretome profile of MSCs derived from human adult bone marrow (BM-MSCs), adipose tissue (AT-MSCs) and Wharton's jelly (WJ-MSCs) cultured in clinically-relevant conditions, with the focus on the neuroregenerative potential. All the cell types were positive for CD10/CD29/CD44/CD73/CD90/CD105/HLA-ABC and negative for CD14/CD45/CD235a/CD271/HLA-DR/VEGFR2 markers, but they differed in the expression of CD34/CD133/CD146/SSEA-4/MSCA-1/CD271/HLA-DR markers. BM-MSCs displayed the highest immunomodulatory activity compared to AT- and WJ-MSCs. On the other hand, BM-MSCs secreted the lower content and had the lower gene expression of neurotrophic growth factors compared to other cell lines, which may be caused by the higher sensitivity of BM-MSCs to nutrient limitations. Despite the differences in growth factor secretion, the MSC secretome derived from all cell sources had a pronounced neurotrophic potential to stimulate the neurite outgrowth of DRG-neurons and reduce the cell death of neural stem/progenitor cells after H2O2 treatment. Overall, our study provides important information for the transfer of basic MSC research towards clinical-grade manufacturing and therapeutic applications.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028396
- 003
- CZ-PrNML
- 005
- 20210114153734.0
- 007
- ta
- 008
- 210105s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-020-61167-z $2 doi
- 035 __
- $a (PubMed)32152403
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Petrenko, Yuriy $u Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14220, Prague, Czech Republic. yuriy.petrenko@iem.cas.cz.
- 245 12
- $a A Comparative Analysis of Multipotent Mesenchymal Stromal Cells derived from Different Sources, with a Focus on Neuroregenerative Potential / $c Y. Petrenko, I. Vackova, K. Kekulova, M. Chudickova, Z. Koci, K. Turnovcova, H. Kupcova Skalnikova, P. Vodicka, S. Kubinova,
- 520 9_
- $a Multipotent mesenchymal stromal cells (MSCs) can be considered an accessible therapeutic tool for regenerative medicine. Here, we compared the growth kinetics, immunophenotypic and immunomodulatory properties, gene expression and secretome profile of MSCs derived from human adult bone marrow (BM-MSCs), adipose tissue (AT-MSCs) and Wharton's jelly (WJ-MSCs) cultured in clinically-relevant conditions, with the focus on the neuroregenerative potential. All the cell types were positive for CD10/CD29/CD44/CD73/CD90/CD105/HLA-ABC and negative for CD14/CD45/CD235a/CD271/HLA-DR/VEGFR2 markers, but they differed in the expression of CD34/CD133/CD146/SSEA-4/MSCA-1/CD271/HLA-DR markers. BM-MSCs displayed the highest immunomodulatory activity compared to AT- and WJ-MSCs. On the other hand, BM-MSCs secreted the lower content and had the lower gene expression of neurotrophic growth factors compared to other cell lines, which may be caused by the higher sensitivity of BM-MSCs to nutrient limitations. Despite the differences in growth factor secretion, the MSC secretome derived from all cell sources had a pronounced neurotrophic potential to stimulate the neurite outgrowth of DRG-neurons and reduce the cell death of neural stem/progenitor cells after H2O2 treatment. Overall, our study provides important information for the transfer of basic MSC research towards clinical-grade manufacturing and therapeutic applications.
- 650 _2
- $a tuková tkáň $x cytologie $x metabolismus $7 D000273
- 650 _2
- $a buňky kostní dřeně $x cytologie $x metabolismus $7 D001854
- 650 12
- $a buněčná diferenciace $7 D002454
- 650 _2
- $a proliferace buněk $7 D049109
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mezenchymální kmenové buňky $x cytologie $x metabolismus $7 D059630
- 650 12
- $a regenerace nervu $7 D009416
- 650 _2
- $a nervové kmenové buňky $x cytologie $x metabolismus $7 D058953
- 650 _2
- $a Whartonův rosol $x cytologie $x metabolismus $7 D059631
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vackova, Irena $u Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14220, Prague, Czech Republic.
- 700 1_
- $a Kekulova, Kristyna $u Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14220, Prague, Czech Republic. 2nd Medical Faculty, Charles University, V Uvalu 84, 15006, Prague, Czech Republic.
- 700 1_
- $a Chudickova, Milada $u Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14220, Prague, Czech Republic.
- 700 1_
- $a Koci, Zuzana $u Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14220, Prague, Czech Republic.
- 700 1_
- $a Turnovcova, Karolina $u Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14220, Prague, Czech Republic.
- 700 1_
- $a Kupcova Skalnikova, Helena $u Institute of Animal Physiology and Genetics of the Czech Academy of Sciences, Rumburska 89, 277 21, Libechov, Czech Republic.
- 700 1_
- $a Vodicka, Petr $u Institute of Animal Physiology and Genetics of the Czech Academy of Sciences, Rumburska 89, 277 21, Libechov, Czech Republic.
- 700 1_
- $a Kubinova, Sarka $u Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14220, Prague, Czech Republic. sarka.kubinova@iem.cas.cz.
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 10, č. 1 (2020), s. 4290
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32152403 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114153731 $b ABA008
- 999 __
- $a ok $b bmc $g 1608731 $s 1119576
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 10 $c 1 $d 4290 $e 20200309 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20210105
